“Our data suggest that microbiota-targeted interventions could mitigate the detrimental effects of early-life antibiotics on ...

polysaccharide-based jab Pneumovax 23. Sanofi's new challenger is billed as a "next-generation" pneumococcal conjugate vaccine that, according to the company, is the first candidate with more than ...

GlaxoSmithKline has agreed a $3.3 billion takeover of US biotech Affinivax, buying a pneumococcal vaccine candidate ... which combines polysaccharide and protein antigens joined with a biotin ...

In addition to increasing vaccine coverage in older adults, they need to monitor the changing epidemiology of pneumococcal serotypes causing invasive disease. [134] In the face of these changes ...

In addition to helping guide future vaccine designs, the hu1B7 and hu11E6 antibodies themselves hold promise as therapeutic medicines for infected and high-risk infants. Previous work by Maynard ...

Peter H. Gilligan, Ph.D., D(ABMM) emeritus and F(AAM) was a medical microbiologist at UNC Health for 35 years. Here, he ...

Many vaccines contain trace amounts of neomycin to prevent bacterial contamination during the manufacturing process. As a topical medicament, neomycin elicits a high sensitization rate.

Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of ...

In addition to guiding future vaccine development, the antibodies hu1B7 and hu11E6 may also serve as therapeutic options for infants who are infected or at high risk. Previous studies suggest these ...

Pneumococcal pneumonia is particularly prevalent in older adults, and here, pneumonia is still associated with significant mortality despite the widespread use of pneumococcal vaccination in middleand ...